| Previous close | 10.54 |
| Open | 10.80 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 90.00 |
| Expiry date | 2024-06-21 |
| Day's range | 10.54 - 10.81 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Reuters
Moderna begins work on China mRNA manufacturing site
U.S. vaccine maker Moderna began construction of its first facility in China this month to manufacture mRNA medicines, the company said on Tuesday. Moderna's COVID-19 vaccine has yet to be approved in China, but the company said in July it had signed a deal with the city government of China's financial hub Shanghai to work towards opportunities for it to research, develop and manufacture mRNA medicines in the country. The facility in Shanghai would manufacture medicines for the domestic population, the world's second largest after India, a spokesperson for Moderna told Reuters.
Insider Monkey11 Best Upside Stocks To Buy Right Now
In this piece, we will take a look at the 11 best upside stocks to buy right now. If you want to skip our overview of share valuation, then take a look at the 5 Best Upside Stocks To Buy Now. The art of buying shares on the market has always gone hand in hand […]
Moneywise‘Nobody wants to speak about COVID’: Less than 3% of eligible Americans got a booster shot in September — does that mean trouble for these 3 big vaccine stocks?
Market performance hangs on U.S. vaccination rates for these three companies.
